
Impiricus
Proprietary HCP engagement platform delivering 8x higher engagement rates with a network of 800,000 HCPs.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | $1.1m | Early VC | |
Total Funding | 000k |
Related Content
Impiricus is a next-generation healthtech platform that operates in the pharmaceutical industry, providing direct access to healthcare providers (HCPs). The company's primary function is to keep HCPs updated with the latest innovations in the pharmaceutical industry. It does this by delivering relevant information at the point-of-care in a seamless and actionable manner. This means that healthcare providers can access the latest medical knowledge and treatments right when they need it, improving patient care.
Impiricus serves a broad range of clients, including pharmaceutical companies and healthcare providers. The company has developed a proprietary network of over 800,000 HCPs, which allows it to reach a large audience and amplify engagement. This network includes both low-see and no-see HCPs, meaning those who are less frequently visited by pharmaceutical representatives and those who are not visited at all.
The company's business model is based on integrating with their clients' teams to understand their objectives and develop custom campaigns that reach and engage their stakeholders. This approach allows Impiricus to deliver eight times the engagement rate of other healthtech platforms.
Impiricus generates revenue by offering its services to pharmaceutical companies and other healthcare organizations. These organizations pay for access to Impiricus's network of HCPs and for the development and implementation of custom campaigns.
In summary, Impiricus is a healthtech platform that connects healthcare providers with the latest pharmaceutical innovations, serving pharmaceutical companies and healthcare providers, and generating revenue through its engagement services.
Keywords: Healthtech platform, Pharmaceutical industry, Healthcare providers, Point-of-care information, Proprietary network, Custom campaigns, Stakeholder engagement, Low-see and no-see HCPs, Revenue generation, Pharmaceutical innovations.